The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications
Open accessAbstract
Bioactive chemical constitutes from the root of Salvia miltiorrhiza classified in two major groups, viz; liposoluble tanshinones and water-soluble phenolics. Tanshinone IIA is a major lipid soluble compound having promising health benefits. The in vivo and in vitro studies showed that the tanshinone IIA and salvianolate have a wide range of cardiovascular and other pharmacological effects, including antioxidative, anti-inflammatory, endothelial protective, myocardial protective, anticoagulation, vasodilation, and anti-atherosclerosis, as well as significantly help to reduce proliferation and migration of vascular smooth muscle cells. In addition, some of the clinical studies reported that the S. miltiorrhiza preparations in combination with Western medicine were more effective for treatment of various cardiovascular diseases including angina pectoris, myocardial infarction, hypertension, hyperlipidemia, and pulmonary heart diseases. In this review we demonstrated the potential applications of S. miltiorrhiza, including pharmacological effects of salvianolate, tanshinone IIA and its water-soluble derivative like sodium tanshinone IIA sulfonate, moreover we also provided details about the clinical applications of S. miltiorrhiza preparations in controlling the cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wu, D., Wang, Y., Han, X., Wen, X., Li, L., Xu, L., Lu, J., & Zheng, Y. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13557 · Cited by 55
RetractedZhao, D., Tong, L., Zhang, L., Li, H., Wan, Y., & Zhang, T. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5916 · Cited by 38
RetractedHeart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Cardiovascular disease in Europe: epidemiological update
Nichols, M., Townsend, N., Scarborough, P., & Rayner, M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht356 · Cited by 1,343
Cardiovascular disease in Europe 2014: epidemiological update
Nichols, M., Townsend, N., Scarborough, P., & Rayner, M. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu299 · Cited by 1,294
Recent insights into the cellular biology of atherosclerosis
Tabas, I., García-Cardeña, G., & Owens, G. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412052 · Cited by 1,016
Controversies in ventricular remodelling
Opie, L. H., Commerford, P. J., Gersh, B. J., & Pfeffer, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68074-4 · Cited by 861
Tsang, A., Hausenloy, D. J., Mocanu, M. M., & Yellon, D. M. (2004) · Circulation Research · doi:10.1161/01.res.0000138303.76488.fe · Cited by 661
Epidemiological studies of CHD and the evolution of preventive cardiology
Wong, N. D. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.26 · Cited by 658
Traditional Chinese Medicine for Cardiovascular Disease
Hao, P., Jiang, F., Cheng, J., Ma, L., Zhang, Y., & Zhao, Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.041 · Cited by 580
Cited by
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G. K., Eid, A. H., & Pintus, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00422 · Cited by 437
Ashraf, M. V., Khan, S., Misri, S., Gaira, K. S., Rawat, S., Rawat, B., Khan, M. A. H., Shah, A. A., Asgher, M., & Ahmad, S. (2024) · Pharmaceuticals · doi:10.3390/ph17080975 · Cited by 102
Recent advances of tanshinone in regulating autophagy for medicinal research
Wu, S., Zhao, K., Wang, J., Liu, N., Nie, K., Qi, L., & Xia, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059360 · Cited by 32
Spirulina and Herbal Combination on Metabolic Alterations of Cardiovascular Diseases (CVDs)
Pandey, R., & Singh, S. (2022) · International Journal of Research and Review · doi:10.52403/ijrr.20220334 · Cited by 6
Metadata
- Authors
- Ren, J., Fu, L., Nile, S. H., Zhang, J., & Kai, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2019-07-05
- Volume
- 10
- Pages
- 753-753
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2954366821
- Cited by
- 305
- References
- 109
- FWCI
- 38.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications. https://app.cochat.ai/papers/10.3389/fphar.2019.00753
- The paper
- Ren, J., Fu, L., Nile, S. H., Zhang, J., & Kai, G. (2019). Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.00753
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.